Search

everythinglearnresearchcommunity

for

Search:↓

PAD3 plays a key role in hair and skin protein structure and may be linked to skin diseases.

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Asiasari radix extract promotes hair growth and increases protein synthesis and cell proliferation.

Cardamonin may help treat oral cancer by promoting cell death and stopping cancer cell growth.

The MPA-ISO cocrystal improved solubility and dissolution rate, while the others did not.

JAK inhibitors are safe and effective for treating moderate-to-severe alopecia areata.

Cyclosporine A helps hair grow by blocking a process that would otherwise cause hair cells to die.

JAK inhibitors show promise in treating difficult skin diseases.

Upadacitinib may help regrow hair in children with alopecia areata and is generally safe.

Thai plant extracts, especially Avicennia marina, can promote hair growth by inhibiting certain enzymes and boosting growth factors.

Adenosine helps human hair grow and prevents hair loss by targeting specific cells.

Changing the 6-position on benzopyran molecules affects insulin release, with some compounds showing strong inhibitory effects.

Nitrendipine and nifedipine effectively block muscle contractions, while papaverine relaxes them and minoxidil needs high amounts to work.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

Apocynin may protect skin cells from aging and damage caused by UVB light.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

JAK inhibitors show promise for treating skin disorders like alopecia, eczema, and psoriasis.

Upadacitinib improved Crohn's disease, atopic dermatitis, and alopecia areata in one patient.

Ritlecitinib effectively improves hair regrowth and physician satisfaction in severe alopecia areata over time.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Ishige sinicola extract helps bone-building cells grow and mature, which could aid in treating osteoporosis.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Scientists found a new gene in a bacterium that can modify an immunosuppressant drug, potentially helping to treat hair loss.

Janus kinase inhibitors are effective for severe alopecia areata, promoting hair regrowth.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.